KTE-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study From the DESCAR-T Registry and LYSA Group

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2022年 / 20卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：15 / 16
页数：2
相关论文
共 50 条
  • [1] Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study from the Descar-T Registry and Lysa Group
    Herbaux, Charles
    Bret, Caroline
    Di Blasi, Roberta
    Bachy, Emmanuel
    Beauvais, David
    Gat, Elodie
    Gastinne, Thomas
    Broussais, Florence
    Cartron, Guillaume
    Cuffel, Alexis
    Ysebaert, Loic
    Roussel, Mikael
    Bouabdallah, Krimo
    Guy, Julien
    Campidelli, Arnaud
    Van Laethem, Francois
    Casasnovas, Rene-Olivier
    Dulery, Remy
    Morschhauser, Franck
    Caillat-Zucman, Sophie
    Houot, Roch
    Le Gouill, Steven
    BLOOD, 2021, 138
  • [2] KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
    Wang, Michael
    Munoz, Javier
    Goy, Andre
    Locke, Frederick L.
    Jacobson, Caron A.
    Hill, Brian T.
    Timmerman, John M.
    Holmes, Houston
    Jaglowski, Samantha
    Flinn, Ian W.
    McSweeney, Peter A.
    Miklos, David B.
    Pagel, John M.
    Kersten, Marie-Jose
    Milpied, Noel
    Fung, Henry
    Topp, Max S.
    Houot, Roch
    Beitinjaneh, Amer
    Peng, Weimin
    Zheng, Lianqing
    Rossi, John M.
    Jain, Rajul K.
    Rao, Arati V.
    Reagan, Patrick M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (14): : 1331 - 1342
  • [3] Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry
    Herbaux, Charles
    Bret, Caroline
    Bachy, Emmanuel
    Bories, Pierre
    Di Blasi, Roberta
    Cuffel, Alexis
    Gastinne, Thomas
    Lamy, Thierry
    Roussel, Mikael
    Bouabdallah, Krimo
    Beauvais, David
    Cartron, Guillaume
    Bay, Jacques-Olivier
    Blaise, Didier
    Rubio, Marie-Therese
    Mohty, Mohamad
    Le Bras, Fabien
    Casasnovas, Olivier
    Guy, Julien
    Guidez, Stephanie
    Llorente, Cristina Castilla
    Hermine, Olivier
    La Rochelle, Laurianne Drieu
    Carras, Sylvain
    Guffroy, Blandine
    Caillat-Zucman, Sophie
    Houot, Roch
    Le Gouill, Steven
    HAEMATOLOGICA, 2024, 109 (11) : 3745 - 3750
  • [4] A Propensity Score-Matched Comparison of Axi-Cel and Tisa-Cel for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Real-Life: A Lysa Study from the Descar-T Registry
    Bachy, Emmanuel
    Le Gouill, Steven
    Di Blasi, Roberta
    Sesques, Pierre
    Cartron, Guillaume
    Beauvais, David
    Roulin, Louise
    Gros, Francois Xavier
    Sylvain, Choquet
    Bories, Pierre
    Rubio, Marie Therese
    Casasnovas, Rene-Olivier
    Bay, Jacques-Olivier
    Mohty, Mohamad
    Joris, Magalie
    Gastinne, Thomas
    Tudesq, Jean Jacques
    Chaillol, Isabelle
    Broussais, Florence
    Thieblemont, Catherine
    Houot, Roch
    Morschhauser, Franck
    BLOOD, 2021, 138
  • [5] Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States
    Simons, Claire L.
    Malone, Daniel
    Wang, Michael
    Maglinte, Gregory A.
    Inocencio, Tim
    Wade, Sally W.
    Bennison, Craig
    Shah, Bijal
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 421 - 431
  • [6] Late Failure of Aggressive B-Cell Lymphoma Following CAR T-Cell Therapy: A Lysa Study from the Descar-T Registry
    Erbella, Federico
    Bachy, Emmanuel
    Cartron, Guillaume
    Gat, Elodie
    Morschhauser, Franck
    Tessoulin, Benoit
    Tournilhac, Olivier
    Sylvain, Choquet
    Gros, Francois-Xavier
    Castilla-Llorente, Cristina
    Campidelli, Arnaud
    Casasnovas, Rene-Olivier
    Roulin, Louise
    Bories, Pierre
    Mohty, Mohamad
    Carre, Martin
    Le Gouill, Steven
    Houot, Roch
    Di Blasi, Roberta
    BLOOD, 2022, 140 : 1325 - 1327
  • [7] PATIENT REPORTED OUTCOMES AMONG KTE-X19 CAR T TREATED PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA (R/R MCL)
    Kersten, Jose M.
    Munoz, J.
    Milpied, N.
    Maglinte, G.
    Crawford, S.
    Solem, C.
    Rao, A., V
    Wang, M.
    VALUE IN HEALTH, 2020, 23 : S479 - S479
  • [8] Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry
    Lemoine, Jean
    Bachy, Emmanuel
    Cartron, Guillaume
    Beauvais, David
    Gastinne, Thomas
    Di Blasi, Roberta
    Rubio, Marie-Therese
    Guidez, Stephanie
    Mohty, Mohamad
    Casasnovas, Rene-Olivier
    Joris, Magalie
    Castilla-Llorente, Cristina
    Haioun, Corinne
    Hermine, Olivier
    Loschi, Michael
    Carras, Sylvain
    Bories, Pierre
    Fradon, Tom
    Herbaux, Charles
    Sesques, Pierre
    Le Gouil, Steven
    Morschhauser, Franck
    Thieblemont, Catherine
    Houot, Roch
    BLOOD ADVANCES, 2023, 7 (21) : 6589 - 6598
  • [9] Anti-CD19 CAR T-Cell Therapy for Patients with Richter Syndrome: A Lysa Study from the Descar-T Registry
    Bensaber, Hedi
    Bachy, Emmanuel
    Beauvais, David
    Dulery, Remy
    Gastinne, Thomas
    Villemagne, Bruno
    Roulin, Louise
    Paubelle, Etienne
    Castilla-Llorente, Cristina
    Longval, Thomas
    Gat, Elodie
    Fayard, Amandine
    Bay, Jacques-Olivier
    Le Gouill, Steven
    Houot, Roch
    Guieze, Romain
    BLOOD, 2022, 140 : 3803 - 3804
  • [10] Anti-CD19 CAR T-cell therapy patients with Richter syndrome: a LYSA Study from the DESCAR-T Registry
    Bensaber, Hedi
    Bachy, Emmanuel
    Dulery, Remy
    Beauvais, David
    Gastinne, Thomas
    Villemagne, Bruno
    Roulin, Louise
    De Guibert, Sophie
    Feugier, Pierre
    Ferrant, Emmanuelle
    Llorente, Cristina Castilla
    Paubelle, Etienne
    Longval, Thomas
    Fayard, Amandine
    Bay, Jacques-Olivier
    Gat, Elodie
    Le Gouill, Steven
    Houot, Roch
    Guieze, Romain
    LEUKEMIA & LYMPHOMA, 2023, 64 : S161 - S162
12345